FDA Investigator Kazi Rafiquzzaman
Kazi Rafiquzzaman has conducted inspections on 6 sites in 1 countries as of 07 Jun 2024. See below for a list of the FDA enforcement documents resulting from those inspections.
Investigator Details
Number of Inspected Sites:
6
Last Inspection Date:
07 Jun 2024
Investigator Role:
FDA Investigator
Redica ID:
Countries of Inspections:
United States of America
FDA Investigators that have inspected at least one site in common with Kazi Rafiquzzaman:
Alberto A Viciedo,
Arduino Frankovic,
Cary Greene,
Charisse K Green,
Charles J Chacko,
Dana A Razzano,
David A Laplante,
David H Smith,
Dennis E Guilfoyle, PhD,
Dr. Robert C Horan, MD,
Eric J Cunningham,
Eric Rothschild,
Erin L Nagel,
Frank J Marciniak,
Gary J Lehr,
Gianine E Tompkins,
Gregory E Beichner,
Helen B Ricalde,
Helen Verdel,
Hilary K Wagner,
Jason M Sluzynski,
Jose V Obando,
Juan Rjimenez Garcia,
Judy Keihl,
Karen E D'orazio,
Kelly Doremus,
Kenneth H Williams,
Kim M Downing,
Kimberley A Ricketts,
Kirk A Dymbrowski,
Kwong P Lee,
Lawrence W Farina,
Li Li,
Linda M Sacco,
Marie Elena C Puleo,
Mary M Finn,
Melba Trivera Clavell,
Melissa A Henaghan,
Melissa T Roy,
Michael R Klapal,
Michael W Burd,
Michele Gottshall,
Milan S Mcgorty,
Nancy F Scheraga,
Paul Mouris,
Philip F Istafanos, DMV, MS,
Richard K Glabach,
Robert C Steyert,
Simone E Pitts,
Sony Mathews,
Tamara M Simpson,
Valentino Fiorella,
Xiaokuang Lai, PhD
Kazi Rafiquzzaman's Documents
Publish Date | Document Type | Title |
---|---|---|
August, 2012 | FDA 483 | Columbia Presbyterian Medical Center - Form 483, 2012-08-10 |
November, 2010 | EIR | Queseria Chipilo, Inc. - EIR, 2010-11-08 |
August, 2012 | FDA 483 | PETNET SOLUTIONS, INC. - Form 483, 2012-08-17 |
December, 2009 | FDA 483 | Unette Corporation - Form 483, 2009-12-30 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more